iSpecimen annual return on equity
2021
2022
2023
2024
2025
iSpecimen Return on Equity (ROE) Growth & History (ISPC)
iSpecimen's return on equity was −327.77% for fiscal 2025.
View full iSpecimen company overviewiSpecimen annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −327.77% | −136.27 pp |
| 2024 | 2024-12-31 | −191.51% | −117.63 pp |
| 2023 | 2023-12-31 | −73.87% | −32.97 pp |
| 2022 | 2022-12-31 | −40.90% | +672.16 pp |
| 2021 | 2021-12-31 | −713.06% | — |
iSpecimen quarterly return on equity
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −106.87% | −15.43 pp |
| Q1 2026 | 2026-03-31 | −116.61% | −50.00 pp |
| Q4 2025 | 2025-12-31 | −162.35% | −11.66 pp |
| Q3 2025 | 2025-09-30 | −150.52% | −123.87 pp |
| Q2 2025 | 2025-06-30 | −91.44% | −58.75 pp |
| Q1 2025 | 2025-03-31 | −66.61% | −31.55 pp |
| Q4 2024 | 2024-12-31 | −150.69% | −123.31 pp |
| Q3 2024 | 2024-09-30 | −26.65% | −11.25 pp |
| Q2 2024 | 2024-06-30 | −32.69% | −11.45 pp |
| Q1 2024 | 2024-03-31 | −35.06% | −22.39 pp |
| Q4 2023 | 2023-12-31 | −27.38% | −17.27 pp |
| Q3 2023 | 2023-09-30 | −15.40% | −2.43 pp |
| Q2 2023 | 2023-06-30 | −21.24% | −11.40 pp |
| Q1 2023 | 2023-03-31 | −12.67% | −4.37 pp |
| Q4 2022 | 2022-12-31 | −10.11% | −0.32 pp |
| Q3 2022 | 2022-09-30 | −12.97% | +0.67 pp |
| Q2 2022 | 2022-06-30 | −9.84% | — |
| Q1 2022 | 2022-03-31 | −8.30% | — |
| Q4 2021 | 2021-12-31 | −9.79% | — |
| Q3 2021 | 2021-09-30 | −13.64% | — |
iSpecimen return on equity trends
Between the periods ended 2021-12-31 and 2025-12-31, iSpecimen's return on equity increased from −713.06% to −327.77%, a change of +385.29 percentage points. The latest reported quarter, Q2 2026, shows −106.87%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review iSpecimen source filings ↗